Article
Successful treatment by glecaprevir/pibrentasvir followed by hepatoprotective therapy of acute chronic hepatitis exacerbation caused by daratumumab-based regimen for multiple myeloma: Case report and review of the literature.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 1 Dec 2021
Yamazaki Tomoo, Joshita Satoru, Ichijo Tetsuya, Kobayashi Hiroyuki, Wakabayashi Shun-Ichi, Yamashita Yuki, Sugiura Ayumi, Kawakami Fumihiro, Nakazawa Hideyuki, Umemura Takeji
Abstract excerpt
Hepatitis C virus (HCV) exacerbation is relatively rare as compared with hepatitis B virus reactivation in patients treated with immunosuppressive or anticancer drugs. We herein present the first reported case of acute exacerbation of chronic hepatitis in a patient with HCV persistent infection caused by combination treatment with daratumumab (DARA), bortezomib, and dexamethasone (DVd therapy). A 79-year-old...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
